Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).

NCT04215796 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Adherence, Medication

Interventions

DEVICE: ReX-C system

Sponsor

Dosentrx Ltd.